 |
인쇄하기
취소
|
Daewoong Pharm ties with Sankyo Co. on hypertension drug
Daewoong Pharm said it would join hands with Sankyo Co Ltd., Japan's second-largest drug maker to promote Sankyo's new one-daily hypertension treatment Olmesartan medoxomil in Korea.
Olmetec, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract. Olmesartan is a selective AT1 subtype angiotensin II receptor antagonist.
No significant drug interactions we...
Olmetec, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract. Olmesartan is a selective AT1 subtype angiotensin II receptor antagonist.
No significant drug interactions we...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.